Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase

Cancer Research

Volumn 61, Issue 4, 2001, Pages 1604-1610

  She, Qing Bai ^a   Bode, Ann M ^a   Ma, Wei Ya ^a   Chen, Nan Yue ^a   Dong, Zigang ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53; RESVERATROL; SYNAPTOPHYSIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER PREVENTION; CELL TRANSFORMATION; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MOUSE; NONHUMAN; PHASE TRANSITION; PRIORITY JOURNAL; TRANSACTIVATION; TRANSCRIPTION REGULATION; TUMOR PROMOTION;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; CELL LINE; ENZYME ACTIVATION; EPIDERMIS; MAP KINASE KINASE 1; MICE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SERINE; STILBENES; TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035866404     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
2. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells
3. Resveratrol, a remarkable inhibitor of ribonucleotide reductase
4. 2 phase transition
5. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway
6. Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model
7. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines
8. AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells
9. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells
10. Requirement for phosphatidylinositol 3-kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells
11. Phosphatidylinositol-3 kinase is necessary for 12-0-tetradecanoylphorbol- 13-acetate-induced cell transformation and activated protein 1 activation
12. JNK activation is required for JB6 cell transformation induced by tumor necrosis factor-α but not by 12-0-tetradecanoylphorbol-13-acetate
13. Multisite phosphorylation and the integration of stress signals at p53
14. The complexity of p53 modulation: Emerging patterns from divergent signals
15. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
16. DNA damage induces phosphorylation of the amino terminus of p53
17. Mutations in serines 15 and 20 of human p53 impair its apoptotic activity
18. Phosphorylation of p53 serine 15 increases interaction with CBP
19. Serine 15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2
20. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
21. Selective activation of c-Jun kinase mitogen-activated protein kinase by CD40 on human B cells
22. Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor α
23. δ to membrane is required for ultraviolet B-induced activation of mitogen-activated protein kinases and apoptosis
24. Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis
25. Mitogen-activated protein kinase pathway mediates hyperoxiainduced apoptosis in cultured macrophage cells
26. 1 phase progression in proliferating hepatocytes
27. Resveratrol-induced activation of the mitogen-activated protein kinases, ERK1 and ERK2, in human neuroblastoma SH-SY5Y cells
28. Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: The potential for multiplex signalling
29. Activation of c-Jun-NH2-kinase by UV irradiation is dependent on p21ras
30. Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells
31. The extracellular-signal-regulated protein kinases (Erks) are required for UV-induced AP-1 activation in JB6 cells
32. Phosphorylation of the tumor suppressor protein p53 by mitogen-activated protein kinases
33. p53 is phosphorylated in vitro and in vivo by an ultraviolet radiation-induced protein kinase characteristic of the c-Jun kinase, JNK1
34. p38 kinase mediates UV-induced phosphorylation of p53 protein at serine 389
35. Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation
36. Structural aspects of the p53 protein in relation to gene evolution
37. Ultraviolet B-induced activated protein-I activation does not require epidermal growth factor receptor but is blocked by a dominant negative PKCλ/l
38. Proteinase inhibitors I and II from potatoes specifically block UV-induced activator protein-1 activation through a pathway that is independent of extracellular signal-regulated kinases, c-Jun N-terminal kinases, and p38 kinase
39. A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum
40. Interferon-γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway
41. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation
42. Essential role of p53 in phenethyl isothiocyanate-induced apoptosis
43. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation
44. No point mutation of Ha-ras or p53 genes expressed in preneoplastic-to-neoplastic progression as modeled in mouse JB6 cell variants
45. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
46. Mdm2 promotes the rapid degradation of p53
47. Regulation of p53 stability by Mdm2
48. Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response element
49. Transforming, G. Protein-coupled receptors potently activate JNK (SAPK). Evidence for a divergence from the tyrosine kinase signaling pathway
50. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo
51. p38/RK is essential for stress-induced nuclear responses: JNK/SAPKs and c-Jun/ATF-2 phosphorylation are insufficient
52. Requirement of Erk, but not JNK for arsenite-induced cell transformation
53. Clinical chemoprevention: Developing a cancer prevention strategy
54. Effect of Dietary phytochemicals on cancer development
55. Perspectives on cancer chemoprevention research and drug development
56. Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression
57. Activation of the ATM kinase by ionizing radiation and phosphorytation of p53
58. A role for ATR in the DNA damage-induced phosphorylation of p53
59. DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage
60. Effects of protein kinase C activators on phorbol ester-sensitive and -resistant EL4 thymoma cells
61. The ras encogene-mediated sensitization of human cells to topoisomerase II inhibitorinduced apoptosis
62. JNK targets p53 ubiquitination and degradation in nonstressed cells
63. MEKK1/JNK signaling stabilizes and activates p53
64. Signal transduction. Three paths to stress relief
65. DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization